Pfizer-BioNTech Covid-19 Vaccine for Young Children to Be Reviewed by FDA Advisers

Experts advising the Food and Drug Administration are scheduled to meet Tuesday to consider endorsing the Covid-19 vaccine from Pfizer Inc. for use in young children. Their positive recommendation would likely soon lead to an expansion of the U.S. vaccination campaign to millions of young children. The FDA last week said the results from the companies’ late-stage study met the criteria for immune responses in children 5 to 11 years. The agency also confirmed data from the companies showing that the shot was found to be safe and 90.7% effective at preventing symptomatic Covid-19 in a study of the youngsters.
The expert panel, called the Vaccines and Related Biological Products Advisory Committee, is expected to review scientific data about the vaccine’s safety and effectiveness in children, and vote to recommend whether the FDA should authorize the use…. (Excerpts from the Wall Street Journal)